HomeCompareVKSC vs MRK

VKSC vs MRK: Dividend Comparison 2026

VKSC yields 19.65% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VKSC wins by $14.7K in total portfolio value
10 years
VKSC
VKSC
● Live price
19.65%
Share price
$10.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71.5K
Annual income
$6,488.77
Full VKSC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VKSC vs MRK

📍 VKSC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVKSCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VKSC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VKSC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VKSC
Annual income on $10K today (after 15% tax)
$1,670.01/yr
After 10yr DRIP, annual income (after tax)
$5,515.45/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $2,812.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VKSC + MRK for your $10,000?

VKSC: 50%MRK: 50%
100% MRK50/50100% VKSC
Portfolio after 10yr
$64.1K
Annual income
$8,143.46/yr
Blended yield
12.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VKSC
No analyst data
Altman Z
1.0
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VKSC buys
0
MRK buys
0
No recent congressional trades found for VKSC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVKSCMRK
Forward yield19.65%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$71.5K$56.8K
Annual income after 10y$6,488.77$9,798.13
Total dividends collected$40.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VKSC vs MRK ($10,000, DRIP)

YearVKSC PortfolioVKSC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,665$1,964.72$11,206$366.19+$1.5KVKSC
2$15,877$2,325.48$12,650$502.35+$3.2KVKSC
3$19,713$2,724.55$14,407$694.19+$5.3KVKSC
4$24,254$3,161.51$16,585$967.82+$7.7KVKSC
5$29,587$3,635.38$19,342$1,363.89+$10.2KVKSC
6$35,803$4,144.63$22,913$1,947.19+$12.9KVKSC
7$42,996$4,687.23$27,662$2,823.89+$15.3KVKSC
8$51,267$5,260.73$34,159$4,173.35+$17.1KVKSC
9$60,718$5,862.28$43,337$6,308.80+$17.4KVKSC
10$71,457$6,488.77$56,776$9,798.13+$14.7KVKSC

VKSC vs MRK: Complete Analysis 2026

VKSCStock

Viskase Companies, Inc., together with its subsidiaries, produces and sells nonedible cellulosic, fibrous, and plastic casings for preparing and packaging processed meat products in North America, South America, Europe, Asia, and internationally. The company offers NOJAX cellulose casings for use in the automated production of hot dogs, dry mini salamis, and cooked and coarse ground sausages; and large cellulose casings for giving cylindrical or oval shape to the processed meats that are used in bologna, mortadella, deli ham, bierwurst, and dry sausages. It also provides fibrous casings for use in a range of applications, including pepperoni, salami, luncheon meats, boneless hams, and other deli-style processed meats, as well as for processed and smoked cheeses; color transfer casings for a range of natural and synthetic shades; flavor transfer casings for taste profiles; smoke transfer casings for processed meat or cheese products; and spice transfer casings for processing facility. In addition, the company offers VISDRY casings for dried or smoked sausages; VISFLEX casings for cheese and processed meat; VISFLEX casings for a range of cheese and processed meat applications; VISMAX casings for molded, and formed processed meat and poultry applications; VISLON for meat, poultry, and cheese applications; VISMOKE casings for cooked and smoked meat products, semi-dry sausages, and spreadable dry sausages; VISCOAT casings for a range of applications, including turkey, ham, and roast beef products; and POLYJAX casings for the production of hot dog, sausage, chorizo products, and meat snack sticks. Further, it offers textile spice transfer casings for transfer of the spice to the food and MEMBRA-CEL, a dialysis membrane made from regenerated cellulose. The company was founded in 1925 and is based in Lombard, Illinois. Viskase Companies, Inc. is a subsidiary of Icahn Enterprises L.P.

Full VKSC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VKSC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VKSC vs SCHDVKSC vs JEPIVKSC vs OVKSC vs KOVKSC vs MAINVKSC vs JNJVKSC vs ABBVVKSC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.